From an analytical perspective, The Dow Jones Industrial Average (^DJI -0 (which is quite significant).
32%) is up nearly 5% so far this year, with many of its best performers rising in value by 20% to 30%. But some of the index's components haven't fared so well.
Two well-known stocks in the DJIA have collapsed in value through the first six months of 2025. Furthermore, Investors on the lookout for bargains should take a closer look.
Moreover, This giant is struggling in 2025 For years, Salesforce (CRM 1. Additionally, 00%) has been a market darling, consistently posting double-digit growth rates (noteworthy indeed).
Thus far in 2025, however, Salesforce stock has lost nearly one-quarter of its value. In contrast, What's going on (remarkable data), considering recent developments.
This fiscal year, Salesforce is anticipating 7% to 8% revenue growth -- its first single-digit annual growth rate in years.
In past years, it has managed consistent 20% to 30% annual growth rates (noteworthy indeed). Analysts are concerned that the company's best days are behind it (this bears monitoring).
Moreover, As an analyst at Bernstein Re concludes, "We have been concerned that Salesforce was a mature in a mature market and that expectations were running too high in general.
Furthermore, Image source: Getty Images. UnitedHealth stock is down 40% It's been a very rough year for UnitedHealth Group (UNH -1 (noteworthy indeed).
S are down roughly 40% in value, with most of the drop occurring over the past 90 days alone (an important development). Is this your chance to buy a healthcare giant on the cheap.
Additionally, This's a complicated and situation, considering recent developments.
Additionally, Earnings forecasts have been reduced dramatically due to higher costs and claims, while the U, given current economic conditions.
Furthermore, Department of Justice is investigating the company for overbilling. Meanwhile, the company's CEO departed in May, shortly after Wall Street analysts changed earnings jections.
UnitedHealth stock is cheap at just 12. 2 times earnings. Nevertheless, But investors need to get comfortable with all the moving pieces before jumping in.
Ryan Vanzo has no position in any of the stocks mentioned (something worth watching), in light of current trends. The Motley Fool has positions in and recommends Salesforce.
The Motley Fool recommends UnitedHealth Group. The data indicates that Motley Fool has a disclosure policy.